STOCK TITAN
  1. Home
  2. Sec-filings
  3. RZLT
  4. [8-K] Rezolute, Inc. Reports Material Event

[8-K] Rezolute, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock RZLT logo
Rezolute Inc

NASDAQ:RZLT

RZLT Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

RZLT Latest News

Oct 9, 2025
Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Sep 17, 2025
Rezolute Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results and Provides Business Update
Sep 2, 2025
Rezolute Announces Alignment with FDA on Streamlined Design for Ongoing Phase 3 Trial of Ersodetug in Tumor Hyperinsulinism
Aug 27, 2025
Rezolute to Participate in Upcoming Investor Conferences
Aug 20, 2025
Rezolute Appoints Seasoned Commercial Executive Sunil Karnawat as Chief Commercial Officer

RZLT Latest SEC Filings

Oct 7, 2025
[DEF 14A] Rezolute, Inc. Definitive Proxy Statement
Sep 17, 2025
[8-K] Rezolute, Inc. Reports Material Event
Sep 22, 2025
[SCHEDULE 13G] Rezolute, Inc. SEC Filing
Sep 22, 2025
[SCHEDULE 13G] Rezolute, Inc. SEC Filing
Sep 17, 2025
[10-K] Rezolute, Inc. Files Annual Report

RZLT Stock Data

802.01M
82.32M
9.68%
90.03%
8.53%
Biotechnology
Pharmaceutical Preparations
Link
United States
REDWOOD CITY